Delivered through precision focus.


With a deep heritage and expertise across our areas of focus, we overcome challenges along every step of the R&D pathway. We’ve been around for almost one hundred years and through focused expansion of our development pipeline, we are building momentum to be around for another hundred. We are forging life-changing external partnerships, creating great possibilities and executing a strong external innovation strategy.

We are dedicating significant firepower to identify and collaborate with external innovators in the development of new assets. With the continued performance of our commercial assets as strong growth platforms, this figure will increase.

R&D in brief

Our R&D teams endeavor to develop innovative therapeutic solutions in our three therapeutic areas. We do this by leveraging an entrepreneurial, collaborative approach to build a sustainable portfolio and bring new treatments to patients worldwide.

Media Image

Harnessing the power of digital

We aim to be at the forefront of digital health technology to drive innovation and improve the experience of physicians and patients.

Our R&D sites

The Group’s four R&D centers are located in the heart of internationally recognized scientific hubs: Paris-Saclay (France), Cambridge (U.S.), Wrexham (U.K.) and Shanghai (China).